Physician profile
Nelson E Seabrook
NPI 1215356431
$7,521.09
in general payments reported to CMS, 2019-2025
32 companies · $2,279 in 2025
The $2,279 reported for 2025 was more than what 82% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $16.13 · 2021: $498 · 2022: $1,096 · 2023: $1,793 · 2024: $1,500 · 2025: $2,279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,544 · Education: $29.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,543.71 |
| Education | $29.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,812.78 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Janssen Biotech, INC. | $396.64 | 2021-2025 | Tremfya, Stelara, Simponi Aria |
| Gilead Sciences, INC. | $362.16 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $317.44 | 2024-2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $301.76 | 2021-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $294.57 | 2024-2025 | Omvoh |
| Pfizer INC. | $293.77 | 2021-2025 | |
| Celgene Corporation | $292.93 | 2022-2024 | Zeposia |
| Takeda Pharmaceuticals U.S.A., INC. | $282.28 | 2022-2025 | Entyvio, Eohilia, Gattex |
| Merck Sharp & Dohme LLC | $258.49 | 2021-2024 | Dificid |
| Genzyme Corporation | $189.36 | 2023-2025 | |
| Celltrion USA INC. | $186.49 | 2024-2025 | Vegzelma, Zymfentra |
| Qol Medical, LLC | $185.40 | 2021-2024 | Sucraid, Sucraid |
| Ardelyx, INC. | $169.74 | 2024-2025 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $155.71 | 2021-2024 | Linzess |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $146.79 | 2021-2025 | Rebyota |
| Intercept Pharmaceuticals, INC. | $146.66 | 2021-2025 | |
| Boston Scientific Corporation | $145.13 | 2021-2024 | Resolution 360 Clip |
| Aimmune Therapeutics, INC. | $87.63 | 2024-2025 | Vowst, Zenpep |
| Phathom Pharmaceuticals, INC. | $81.97 | 2023-2025 | Voquezna |
| Daiichi Sankyo INC. | $74.24 | 2023-2024 | Injectafer |
| Madrigal Pharmaceuticals | $57.04 | 2024-2025 | Rezdiffra, Resmetirom |
| Nestle Healthcare Nutrition INC. | $56.33 | 2022-2023 | |
| Ipsen Biopharmaceuticals, INC | $41.89 | 2025 | Iqirvo |
| Fresenius Kabi USA, LLC | $40.64 | 2024 | Idacio |
| Redhill Biopharma INC. | $37.92 | 2021-2022 | |
| Medtronic, INC. | $22.67 | 2024 | Pillcam |
| W. L. Gore & Associates, INC. | $20.54 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.03 | 2022 | |
| Alnylam Pharmaceuticals INC. | $16.68 | 2021 | |
| Amgen INC. | $15.44 | 2022 | |
| Organon LLC | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Seabrook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.